Understanding rural risk environments for drug-related harms: Progress, challenges, and steps forward

Umedjon Ibragimov; April M. Young; Hannah L.F. Cooper

doi:10.1016/j.drugpo.2020.102926

Understanding rural risk environments for drug-related harms: Progress, challenges, and steps forward

Umedjon Ibragimov
, April M. Young
, Hannah L.F. Cooper

Epidemiology & Environmental Health

Research output: Contribution to journal › Editorial

19 Scopus citations

Original language	English
Article number	102926
Journal	International Journal of Drug Policy
Volume	85
DOIs	https://doi.org/10.1016/j.drugpo.2020.102926
State	Published - Nov 2020

Bibliographical note

Funding Information:
This publication has been supported by National Institute on Drug Abuse (NIDA) ( R21 DA042727 ; PIs: Cooper and Young; UG3/UH3 DA044798; PIs: Young and Cooper). Several publications in this special issue were prepared within the Rural Opioid Initiative funded by NIDA . These studies include articles by Cooper et al. (UG3DA044798; UH3DA044798), Fadanelli et al., (UG3DA044798), Kolak et al. (5UG3DA044829-02); Richard et al. (UG3DA044822) and a viewpoint by Jenkins and Hagan (UG3DA044798, UG3DA044829, UG3DA044822, UG3DA044823, UG3DA044831, UG3DA044826, UG3DA044830, UG3DA044825).

Funding Information:
This publication has been supported by National Institute on Drug Abuse (NIDA) (R21 DA042727; PIs: Cooper and Young; UG3/UH3 DA044798; PIs: Young and Cooper). Several publications in this special issue were prepared within the Rural Opioid Initiative funded by NIDA. These studies include articles by Cooper et al. (UG3DA044798; UH3DA044798), Fadanelli et al. (UG3DA044798), Kolak et al. (5UG3DA044829-02); Richard et al. (UG3DA044822) and a viewpoint by Jenkins and Hagan (UG3DA044798, UG3DA044829, UG3DA044822, UG3DA044823, UG3DA044831, UG3DA044826, UG3DA044830, UG3DA044825).

Funding

This publication has been supported by National Institute on Drug Abuse (NIDA) ( R21 DA042727 ; PIs: Cooper and Young; UG3/UH3 DA044798; PIs: Young and Cooper). Several publications in this special issue were prepared within the Rural Opioid Initiative funded by NIDA . These studies include articles by Cooper et al. (UG3DA044798; UH3DA044798), Fadanelli et al., (UG3DA044798), Kolak et al. (5UG3DA044829-02); Richard et al. (UG3DA044822) and a viewpoint by Jenkins and Hagan (UG3DA044798, UG3DA044829, UG3DA044822, UG3DA044823, UG3DA044831, UG3DA044826, UG3DA044830, UG3DA044825). This publication has been supported by National Institute on Drug Abuse (NIDA) (R21 DA042727; PIs: Cooper and Young; UG3/UH3 DA044798; PIs: Young and Cooper). Several publications in this special issue were prepared within the Rural Opioid Initiative funded by NIDA. These studies include articles by Cooper et al. (UG3DA044798; UH3DA044798), Fadanelli et al. (UG3DA044798), Kolak et al. (5UG3DA044829-02); Richard et al. (UG3DA044822) and a viewpoint by Jenkins and Hagan (UG3DA044798, UG3DA044829, UG3DA044822, UG3DA044823, UG3DA044831, UG3DA044826, UG3DA044830, UG3DA044825).

Funders	Funder number
National Institute on Drug Abuse	UG3DA044830, UG3DA044822, UG3DA044823, UG3DA044798, UG3DA044831, UG3DA044826, R21 DA042727, UG3DA044825, UG3DA044829

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Medicine (miscellaneous)
Health Policy

Access to Document

10.1016/j.drugpo.2020.102926

Cite this

@article{28caa41992fd45c695ab44733dfa14bd,

title = "Understanding rural risk environments for drug-related harms: Progress, challenges, and steps forward",

author = "Umedjon Ibragimov and Young, \{April M.\} and Cooper, \{Hannah L.F.\}",

note = "Funding Information: This publication has been supported by National Institute on Drug Abuse (NIDA) ( R21 DA042727 ; PIs: Cooper and Young; UG3/UH3 DA044798; PIs: Young and Cooper). Several publications in this special issue were prepared within the Rural Opioid Initiative funded by NIDA . These studies include articles by Cooper et al. (UG3DA044798; UH3DA044798), Fadanelli et al., (UG3DA044798), Kolak et al. (5UG3DA044829-02); Richard et al. (UG3DA044822) and a viewpoint by Jenkins and Hagan (UG3DA044798, UG3DA044829, UG3DA044822, UG3DA044823, UG3DA044831, UG3DA044826, UG3DA044830, UG3DA044825). Funding Information: This publication has been supported by National Institute on Drug Abuse (NIDA) (R21 DA042727; PIs: Cooper and Young; UG3/UH3 DA044798; PIs: Young and Cooper). Several publications in this special issue were prepared within the Rural Opioid Initiative funded by NIDA. These studies include articles by Cooper et al. (UG3DA044798; UH3DA044798), Fadanelli et al. (UG3DA044798), Kolak et al. (5UG3DA044829-02); Richard et al. (UG3DA044822) and a viewpoint by Jenkins and Hagan (UG3DA044798, UG3DA044829, UG3DA044822, UG3DA044823, UG3DA044831, UG3DA044826, UG3DA044830, UG3DA044825).",

year = "2020",

month = nov,

doi = "10.1016/j.drugpo.2020.102926",

language = "English",

volume = "85",

}

TY - JOUR

T1 - Understanding rural risk environments for drug-related harms

T2 - Progress, challenges, and steps forward

AU - Ibragimov, Umedjon

AU - Young, April M.

AU - Cooper, Hannah L.F.

N1 - Funding Information: This publication has been supported by National Institute on Drug Abuse (NIDA) ( R21 DA042727 ; PIs: Cooper and Young; UG3/UH3 DA044798; PIs: Young and Cooper). Several publications in this special issue were prepared within the Rural Opioid Initiative funded by NIDA . These studies include articles by Cooper et al. (UG3DA044798; UH3DA044798), Fadanelli et al., (UG3DA044798), Kolak et al. (5UG3DA044829-02); Richard et al. (UG3DA044822) and a viewpoint by Jenkins and Hagan (UG3DA044798, UG3DA044829, UG3DA044822, UG3DA044823, UG3DA044831, UG3DA044826, UG3DA044830, UG3DA044825). Funding Information: This publication has been supported by National Institute on Drug Abuse (NIDA) (R21 DA042727; PIs: Cooper and Young; UG3/UH3 DA044798; PIs: Young and Cooper). Several publications in this special issue were prepared within the Rural Opioid Initiative funded by NIDA. These studies include articles by Cooper et al. (UG3DA044798; UH3DA044798), Fadanelli et al. (UG3DA044798), Kolak et al. (5UG3DA044829-02); Richard et al. (UG3DA044822) and a viewpoint by Jenkins and Hagan (UG3DA044798, UG3DA044829, UG3DA044822, UG3DA044823, UG3DA044831, UG3DA044826, UG3DA044830, UG3DA044825).

PY - 2020/11

Y1 - 2020/11

UR - https://www.scopus.com/pages/publications/85090483799

UR - https://www.scopus.com/pages/publications/85090483799#tab=citedBy

U2 - 10.1016/j.drugpo.2020.102926

DO - 10.1016/j.drugpo.2020.102926

M3 - Editorial

C2 - 32912825

AN - SCOPUS:85090483799

SN - 0955-3959

VL - 85

JO - International Journal of Drug Policy

JF - International Journal of Drug Policy

M1 - 102926

ER -

Understanding rural risk environments for drug-related harms: Progress, challenges, and steps forward

Bibliographical note

Funding

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this